Treatment for Dupuytren's disease
Musculoskeletal fibroproliferative disorders, such as Dupuytren's disease may be treated by administering locally a TNF-alpha antagonist. TNF-alpha antagonists find particular utility in inhibiting the progression of early disease state Dupuytren's disease and other musculoskeletal fibropr...
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | English |
| Veröffentlicht: |
2013
|